ZA967137B - Use of aminoadamantane compounds as immunoregulators - Google Patents

Use of aminoadamantane compounds as immunoregulators

Info

Publication number
ZA967137B
ZA967137B ZA967137A ZA967137A ZA967137B ZA 967137 B ZA967137 B ZA 967137B ZA 967137 A ZA967137 A ZA 967137A ZA 967137 A ZA967137 A ZA 967137A ZA 967137 B ZA967137 B ZA 967137B
Authority
ZA
South Africa
Prior art keywords
aminoadamantane
immunoregulators
compounds
aminoadamantane compounds
neutrophils
Prior art date
Application number
ZA967137A
Other languages
English (en)
Inventor
Erich F Elstner
Original Assignee
Merz & Co Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz & Co Gmbh & Co filed Critical Merz & Co Gmbh & Co
Publication of ZA967137B publication Critical patent/ZA967137B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA967137A 1995-08-25 1996-08-22 Use of aminoadamantane compounds as immunoregulators ZA967137B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19531342A DE19531342B4 (de) 1995-08-25 1995-08-25 Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren

Publications (1)

Publication Number Publication Date
ZA967137B true ZA967137B (en) 1997-03-12

Family

ID=7770407

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA967137A ZA967137B (en) 1995-08-25 1996-08-22 Use of aminoadamantane compounds as immunoregulators

Country Status (21)

Country Link
US (2) US6172116B1 (zh)
EP (2) EP1293201A3 (zh)
JP (1) JPH11512093A (zh)
KR (1) KR100392986B1 (zh)
CN (1) CN1282452C (zh)
AT (1) ATE234083T1 (zh)
AU (1) AU718219B2 (zh)
CA (1) CA2230159C (zh)
CZ (1) CZ299356B6 (zh)
DE (3) DE19531342B4 (zh)
DK (1) DK0845984T3 (zh)
EE (1) EE04261B1 (zh)
ES (1) ES2193259T3 (zh)
GE (1) GEP19991779B (zh)
IL (1) IL123394A (zh)
MX (1) MX217078B (zh)
NO (1) NO319153B1 (zh)
RU (1) RU2219916C2 (zh)
UA (1) UA57711C2 (zh)
WO (1) WO1997007791A1 (zh)
ZA (1) ZA967137B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2331905T3 (es) * 1999-04-28 2010-01-20 Bellus Health (International) Limited Composiciones y procedimientos para tratar la amiloidosis usando derivados sulfanato.
US6444702B1 (en) 2000-02-22 2002-09-03 Neuromolecular, Inc. Aminoadamantane derivatives as therapeutic agents
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
UA79908C2 (en) * 2004-06-24 2007-07-25 Olainfarm Joint Stock Company Application of polymeric salts 3,5-dimethyl-1-adamantilammonium as immunostimulative and interferonogenous agent
EP1836161B1 (en) 2004-12-22 2016-07-20 BHI Limited Partnership Methods and compositions for treating amyloid-related diseases
DK3851447T3 (da) 2006-10-12 2023-12-04 Bellus Health Inc Fremgangsmåder, forbindelser, sammensætninger og vehikler til administration af 3-amino-1-propansulfonsyre
JP5812295B2 (ja) * 2010-08-09 2015-11-11 塩野義製薬株式会社 アミノアダマンタンカルバメート誘導体の製造方法
JP7174632B2 (ja) 2016-06-23 2022-11-17 コリウム， インコーポレイテッド 親水性ドメインおよび疎水性ドメインならびに処置剤との接着剤マトリックス
US20180028461A1 (en) 2016-07-27 2018-02-01 Corium International, Inc. Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
EP3490541A2 (en) 2016-07-27 2019-06-05 Corium International, Inc. Transdermal formulation and delivery method of low solubility or unstable unionized neutral drugs byin situ
MX2019001104A (es) 2016-07-27 2019-10-02 Corium Int Inc Sistemas de suministro transdermico de memantina.
WO2019126531A1 (en) 2017-12-20 2019-06-27 Corium, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3450761A (en) * 1967-03-30 1969-06-17 Sun Oil Co 1-aminoethyldimethyladamantane
DE4014672A1 (de) * 1990-05-08 1991-11-14 Werner E G Prof Dr Mueller Verwendung von adamantan-derivaten zur zytoprotektion von nicht-infizierten und virus-infizierten lymphozyten als auch anderen zelltypen

Also Published As

Publication number Publication date
DK0845984T3 (da) 2003-06-23
NO980793L (no) 1998-02-25
CZ52498A3 (cs) 1999-04-14
CZ299356B6 (cs) 2008-07-02
EP0845984A1 (en) 1998-06-10
EP0845984B1 (en) 2003-03-12
MX9801496A (es) 1998-05-31
KR100392986B1 (ko) 2003-11-17
UA57711C2 (uk) 2003-07-15
DE69626650T2 (de) 2003-12-18
IL123394A0 (en) 1998-09-24
WO1997007791A1 (en) 1997-03-06
ES2193259T3 (es) 2003-11-01
DE19531342B4 (de) 2007-11-29
KR19990044096A (ko) 1999-06-25
US6255348B1 (en) 2001-07-03
US6172116B1 (en) 2001-01-09
EP1293201A3 (en) 2003-05-21
JPH11512093A (ja) 1999-10-19
IL123394A (en) 2004-07-25
DE69626650D1 (de) 2003-04-17
ATE234083T1 (de) 2003-03-15
GEP19991779B (en) 1999-10-05
AU6926396A (en) 1997-03-19
NO319153B1 (no) 2005-06-27
MX217078B (es) 2003-10-22
CN1198669A (zh) 1998-11-11
DE10399029I1 (de) 2004-01-08
DE19531342A1 (de) 1997-02-27
AU718219B2 (en) 2000-04-13
CA2230159C (en) 2008-02-26
EE9800057A (et) 1998-08-17
EP1293201A2 (en) 2003-03-19
EE04261B1 (et) 2004-04-15
NO980793D0 (no) 1998-02-25
RU2219916C2 (ru) 2003-12-27
CN1282452C (zh) 2006-11-01
CA2230159A1 (en) 1997-03-06

Similar Documents

Publication Publication Date Title
ZA967137B (en) Use of aminoadamantane compounds as immunoregulators
RU94041950A (ru) Использование соединений ряда 3-аролоксипропиламинов в лечении недержания
AU1373499A (en) Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease
RU94038043A (ru) Применение замещенных производных аденина для лечения множественного склероза
NZ251320A (en) Bis-aromatic alpha,beta-unsaturated ketones, preparation and use in pharmaceutical compositions
CA2135768A1 (en) Indolocarbazole imides and the use thereof
IL126366A0 (en) Photopheresis treatment of leukocytes
CA2079342A1 (en) Multi-functional pharmaceutical compounds and methods of use
HU910681D0 (en) Medical solution
AU2549797A (en) Xanthone analogs for the treatment of infectious diseases
AU693833B2 (en) Products containing G-CSF and TNF binding protein
WO2003013424A3 (en) Use of r-nsaid compounds for anti-hiv treatment
GR3032363T3 (en) Substituted cinnamic acid guanidides, process for their preparation, their use as cardiovascualr medicament or diagnostic agent, as well as medicament containing them
DE3664631D1 (en) Polyprenyl compounds, processes for preparing them, and pharmaceutical composition containing them
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
DE68901172D1 (de) (-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend.
OA09197A (fr) "Peptides SDK, leur procédé de préparation ainsi que des compositions thérapeutiques en contenant".
AU665052B2 (en) The use of a compound for the manufacture of a medicament for the treatment of HIV infection
AU3881889A (en) Human interferon-gamma, process to prepare said human interferon-gamma, and its use
Salmaso et al. Serratia spp. bacteremias in AIDS/ARC patients.
TH24203A (th) อนุพันธ์ของออพทิคัลลี แอคทีฟ เบนโซไชอีพิน การเตรียมและการใช้ประโยชน์ของสารเหล่านี้
GB9218223D0 (en) The use of a compound for the manufacture of a medicament for the treatment of hiv infection
GB9201764D0 (en) The use of a compound for the manufacture of a medicament for the treatment of hiv infection
UA10093A (uk) Спосіб лікування захворювань товстої кишки